IPCA LABS has announced its results for the quarter ended December 2020. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Dec-19* | 3 Sep-20* | 3 Dec-20* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 11,391 | 12,978 | 13,152 | 1.3% | 15.5% |
Other income | Rs m | 176 | 150 | 157 | 4.3% | -11.2% |
Turnover | Rs m | 11,567 | 13,128 | 13,309 | 1.4% | 15.1% |
Expenses | Rs m | 8,736 | 9,376 | 9,664 | 3.1% | 10.6% |
Gross profit | Rs m | 2,654 | 3,602 | 3,488 | -3.1% | 31.4% |
Depreciation | Rs m | 462 | 463 | 477 | 3.0% | 3.2% |
Interest | Rs m | 38 | 18 | 16 | -13.8% | -58.9% |
Profit before tax | Rs m | 2,331 | 3,271 | 3,153 | -3.6% | 35.2% |
Tax | Rs m | 365 | 514 | 553 | 7.5% | 51.6% |
Profit after tax | Rs m | 1,966 | 2,757 | 2,600 | -5.7% | 32.2% |
Gross profit margin | % | 23.3 | 27.8 | 26.5 | ||
Effective tax rate | % | 15.6 | 15.7 | 17.5 | ||
Net profit margin | % | 17.0 | 21.0 | 19.5 |
To see how IPCA LABS has performed over the last eight quarters,please visit here.
Urgent New Alert: About Coming Once-in-a-generation Wealth Shift
Over the last one year, IPCA LABS share price has moved up from Rs 1,220.7 to Rs 1,947.1, registering a Gain of Rs 726.4 or around 59.5%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,735.0 (up 0.5%). Over the last one year it has moved up from 13,946.5 to 21,735.0, a gain of 7,788 points (up 55.8%).
Overall, the S&P BSE SENSEX is up 27.4% over the year.
At the current price of Rs 1,947.1, the price to earnings (P/E) ratio of IPCA LABS stands at 22.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 7.9 times.
For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.
For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.
More Views on NewsIn this video, I'll tell you why I am recommending caution in the market at this time.
A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
In this video I'll show you exactly how I go about picking stocks for trading.
100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
More
| |
Equitymaster requests your view! Post a comment on "IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!